[Evaluation of the Stability and Antibacterial Activity of Burow's and Neo-Burow's Solutions was Prepared Using Different Methods].

IF 0.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan Pub Date : 2024-01-01 DOI:10.1248/yakushi.24-00082
Masako Kinoshita, Rina Yamagishi, Yohei Iizaka, Masaki Takigawa, Yojiro Anzai, Atsushi Urano, Kaoru Hirose, Takehisa Hanawa, Hiroyuki Tanaka
{"title":"[Evaluation of the Stability and Antibacterial Activity of Burow's and Neo-Burow's Solutions was Prepared Using Different Methods].","authors":"Masako Kinoshita, Rina Yamagishi, Yohei Iizaka, Masaki Takigawa, Yojiro Anzai, Atsushi Urano, Kaoru Hirose, Takehisa Hanawa, Hiroyuki Tanaka","doi":"10.1248/yakushi.24-00082","DOIUrl":null,"url":null,"abstract":"<p><p>Burow's solution is a 13% aluminum acetate solution used for treating chronic suppurative otitis media. However, multiple formulations for Burow's and neo-Burow's solutions are used as in-hospital preparations. Each formulation uses different types and amounts of reagents, and takes a different time to prepare. Thus, the ions, including aluminum ion (Al<sup>3+</sup>), and other molecules in the prepared Burow's and neo-Burow's solutions are not identical, and the pH also differs. Furthermore, details about the antibacterial activity of these preparations are unknown. This study evaluated the stability and antibacterial activity of four Burow's and two neo-Burow's solutions prepared using different methods. Preparation times ranged from 20 min to 3 d, and the pH ranged from 2.2 to 4, meaning some solutions were more acidic or more basic than the pH 3 devised by Burow. In addition, the Al<sup>3+</sup> concentrations ranged from 0.05 to 1.51 mol/L, meaning some solutions were more concentrated or diluted than 13% aluminum acetate (0.64 mol/L). One of the Burow's solutions we prepared produced a white residue after 14 d, making it difficult to ensure stability. In addition, confirming the antibacterial activity of another Burow's solution against the test bacteria was problematic. Despite the differences in pH and Al<sup>3+</sup> concentrations between the various Burow's and neo-Burow's solutions, the antibacterial activity was equivalent. It was considered necessary to use the basic data obtained in this study to select a formulation for each hospital. Evaluation of the antibacterial activity of each formulation in clinical settings will be a subject for future study.</p>","PeriodicalId":23810,"journal":{"name":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/yakushi.24-00082","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Burow's solution is a 13% aluminum acetate solution used for treating chronic suppurative otitis media. However, multiple formulations for Burow's and neo-Burow's solutions are used as in-hospital preparations. Each formulation uses different types and amounts of reagents, and takes a different time to prepare. Thus, the ions, including aluminum ion (Al3+), and other molecules in the prepared Burow's and neo-Burow's solutions are not identical, and the pH also differs. Furthermore, details about the antibacterial activity of these preparations are unknown. This study evaluated the stability and antibacterial activity of four Burow's and two neo-Burow's solutions prepared using different methods. Preparation times ranged from 20 min to 3 d, and the pH ranged from 2.2 to 4, meaning some solutions were more acidic or more basic than the pH 3 devised by Burow. In addition, the Al3+ concentrations ranged from 0.05 to 1.51 mol/L, meaning some solutions were more concentrated or diluted than 13% aluminum acetate (0.64 mol/L). One of the Burow's solutions we prepared produced a white residue after 14 d, making it difficult to ensure stability. In addition, confirming the antibacterial activity of another Burow's solution against the test bacteria was problematic. Despite the differences in pH and Al3+ concentrations between the various Burow's and neo-Burow's solutions, the antibacterial activity was equivalent. It was considered necessary to use the basic data obtained in this study to select a formulation for each hospital. Evaluation of the antibacterial activity of each formulation in clinical settings will be a subject for future study.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[用不同方法制备的布罗氏溶液和新布罗氏溶液的稳定性和抗菌活性评估]。
布罗氏溶液是一种 13% 的醋酸铝溶液,用于治疗慢性化脓性中耳炎。不过,布罗氏溶液和新布罗氏溶液有多种配方可用作院内制剂。每种配方使用的试剂类型和数量不同,配制时间也不同。因此,配制的布罗氏溶液和新布罗氏溶液中的离子(包括铝离子(Al3+))和其他分子并不相同,pH 值也不同。此外,有关这些制剂抗菌活性的详细信息也不得而知。本研究评估了用不同方法制备的四种布罗氏溶液和两种新布罗氏溶液的稳定性和抗菌活性。制备时间从 20 分钟到 3 天不等,pH 值从 2.2 到 4 不等,这意味着有些溶液比布罗设计的 pH 值 3 更酸或更碱。此外,Al3+浓度从 0.05 摩尔/升到 1.51 摩尔/升不等,这意味着有些溶液比 13% 的醋酸铝(0.64 摩尔/升)更浓或更稀。我们配制的其中一种布罗氏溶液在 14 天后产生了白色残留物,因此很难确保其稳定性。此外,确认另一种布罗氏溶液对测试细菌的抗菌活性也存在问题。尽管各种布罗氏溶液和新布罗氏溶液的 pH 值和 Al3+ 浓度不同,但抗菌活性却相当。我们认为有必要利用本研究获得的基本数据为每家医院选择一种配方。在临床环境中评估每种配方的抗菌活性将是今后研究的一个主题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
169
审稿时长
1 months
期刊最新文献
[Development of an Odor Evaluation Method for Citrus Unshiu Peel Using an Electronic Nose Based on the Intensity of per Unit Length (INPULTH)]. [The Impact of a Picture Book to Improve Medication Compliance in Pediatric Patients: A Questionnaire Survey]. [What is the Initiating Reaction for the Lipid Radical Chain Reaction System That Can Induce Ferroptotic Cell Death at the Lower Oxygen Content?] [Exploration of Risk Factors of the Onset of Antibiotics-induced Acute Kidney Injury and Its Transfer to Chronic Kidney Disease Using the Medical Information Database]. [Xanthan Gum-based Food Thickeners Reduce Disintegration Time of Medical and OTC Loxoprofen Sodium Tablets].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1